DK3801515T3 - 5 [[4 [2 [5 (1 hydroxyethyl)pyridin 2 yl]ethoxy]phenyl]methyl] 1,3 thiazolidin 2,4 dion og dets salte til anvendelse i behandlingen af mitokondriesygdomme - Google Patents
5 [[4 [2 [5 (1 hydroxyethyl)pyridin 2 yl]ethoxy]phenyl]methyl] 1,3 thiazolidin 2,4 dion og dets salte til anvendelse i behandlingen af mitokondriesygdomme Download PDFInfo
- Publication number
- DK3801515T3 DK3801515T3 DK19742480.7T DK19742480T DK3801515T3 DK 3801515 T3 DK3801515 T3 DK 3801515T3 DK 19742480 T DK19742480 T DK 19742480T DK 3801515 T3 DK3801515 T3 DK 3801515T3
- Authority
- DK
- Denmark
- Prior art keywords
- mitochondral
- thiazolidine
- dione
- pyridin
- ethoxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18382397 | 2018-06-06 | ||
| PCT/IB2019/054696 WO2019234664A1 (en) | 2018-06-06 | 2019-06-06 | 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione and its salts for use in the treatment of mitochondrial diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3801515T3 true DK3801515T3 (da) | 2025-04-28 |
Family
ID=62716008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19742480.7T DK3801515T3 (da) | 2018-06-06 | 2019-06-06 | 5 [[4 [2 [5 (1 hydroxyethyl)pyridin 2 yl]ethoxy]phenyl]methyl] 1,3 thiazolidin 2,4 dion og dets salte til anvendelse i behandlingen af mitokondriesygdomme |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11957670B2 (https=) |
| EP (2) | EP3801515B1 (https=) |
| JP (1) | JP7376934B2 (https=) |
| DK (1) | DK3801515T3 (https=) |
| ES (1) | ES3028538T3 (https=) |
| FI (1) | FI3801515T3 (https=) |
| HR (1) | HRP20250591T1 (https=) |
| HU (1) | HUE071482T2 (https=) |
| LT (1) | LT3801515T (https=) |
| PL (1) | PL3801515T3 (https=) |
| PT (1) | PT3801515T (https=) |
| SI (1) | SI3801515T1 (https=) |
| WO (1) | WO2019234664A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130158077A1 (en) | 2011-12-19 | 2013-06-20 | Ares Trading S.A. | Pharmaceutical compositions |
| JP7734917B2 (ja) | 2019-01-28 | 2025-09-08 | ミトコンドリア エモーション， インク． | トランス－４－ヒドロキシシクロヘキシルフェニルアミドマイトフュージン活性化物質及びその使用方法 |
| AU2019427489B2 (en) | 2019-01-28 | 2025-03-13 | Mitochondria Emotion, Inc. | Mitofusin activators and methods of use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA201391017A1 (ru) | 2011-01-10 | 2014-04-30 | Зинфандел Фармасьютикалз, Инк. | Способы и готовые лекарственные формы для лечения болезни альцгеймера |
| WO2014210389A1 (en) | 2013-06-26 | 2014-12-31 | Rett Syndrome Research Trust | Rett syndrome and treatments therefore |
| EP3094328B1 (en) | 2014-01-15 | 2020-08-19 | Poxel SA | Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone |
| EA202091120A3 (ru) | 2014-04-02 | 2020-12-30 | Минорикс Терапьютикс С.Л. | Производные 2,4-тиазолинидона в лечении расстройств центральной нервной системы |
| JP6791154B2 (ja) | 2015-09-30 | 2020-11-25 | 株式会社ニコン | 露光装置、フラットパネルディスプレイの製造方法、及びデバイス製造方法 |
| WO2017083739A1 (en) | 2015-11-13 | 2017-05-18 | The Trustees Of Columbia University In The City Of New York | A method for predicting a subject's response to valproic acid therapy |
| CN106202285A (zh) | 2016-06-30 | 2016-12-07 | 北京百度网讯科技有限公司 | 搜索结果展示方法和装置 |
| JP7040798B2 (ja) | 2016-12-01 | 2022-03-23 | ミノリックス セラピューティクス エセ．エレ． | 非アルコール性脂肪性肝疾患を処置するための５－［［４－［２－［５－（１－ヒドロキシエチル）ピリジン－２－イル］エトキシ］フェニル］メチル］－１，３－チアゾリジン－２，４－ジオン |
| ES2926580T3 (es) | 2016-12-23 | 2022-10-27 | Minoryx Therapeutics S L | Proceso para preparar 5-[[4-[2-[5-(1-hidroxietil)-2-piridinil]etoxi]fenil]metil]-2,4-tiazolidindiona y sales de la misma |
| CN112823004A (zh) | 2018-06-06 | 2021-05-18 | 米尼奥尔克斯治疗有限公司 | 5-[[4-[2-[5-乙酰基吡啶-2-基]乙氧基]苄基]-1,3-噻唑烷-2,4-二酮及其盐的用途 |
| CN112512524A (zh) | 2018-06-06 | 2021-03-16 | 米尼奥尔克斯治疗有限公司 | 给予治疗有效量的5-[[4-[2-[5-(1-羟基乙基)吡啶-2-基]乙氧基]苯基]甲基]-1,3-噻唑烷-2,4-二酮的方法 |
-
2019
- 2019-06-06 EP EP19742480.7A patent/EP3801515B1/en active Active
- 2019-06-06 LT LTEPPCT/IB2019/054696T patent/LT3801515T/lt unknown
- 2019-06-06 US US16/972,375 patent/US11957670B2/en active Active
- 2019-06-06 PT PT197424807T patent/PT3801515T/pt unknown
- 2019-06-06 SI SI201930937T patent/SI3801515T1/sl unknown
- 2019-06-06 ES ES19742480T patent/ES3028538T3/es active Active
- 2019-06-06 EP EP25162244.5A patent/EP4545142A3/en active Pending
- 2019-06-06 HU HUE19742480A patent/HUE071482T2/hu unknown
- 2019-06-06 FI FIEP19742480.7T patent/FI3801515T3/fi active
- 2019-06-06 PL PL19742480.7T patent/PL3801515T3/pl unknown
- 2019-06-06 WO PCT/IB2019/054696 patent/WO2019234664A1/en not_active Ceased
- 2019-06-06 DK DK19742480.7T patent/DK3801515T3/da active
- 2019-06-06 JP JP2020567815A patent/JP7376934B2/ja active Active
- 2019-06-06 HR HRP20250591TT patent/HRP20250591T1/hr unknown
-
2024
- 2024-04-12 US US18/633,922 patent/US20250064791A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PL3801515T3 (pl) | 2025-07-14 |
| PT3801515T (pt) | 2025-06-11 |
| EP3801515B1 (en) | 2025-04-09 |
| US20250064791A1 (en) | 2025-02-27 |
| SI3801515T1 (sl) | 2025-07-31 |
| ES3028538T3 (en) | 2025-06-19 |
| JP7376934B2 (ja) | 2023-11-09 |
| EP3801515A1 (en) | 2021-04-14 |
| LT3801515T (lt) | 2025-06-10 |
| JP2021527049A (ja) | 2021-10-11 |
| HUE071482T2 (hu) | 2025-08-28 |
| US20210228559A1 (en) | 2021-07-29 |
| EP4545142A3 (en) | 2025-06-11 |
| WO2019234664A1 (en) | 2019-12-12 |
| HRP20250591T1 (hr) | 2025-07-04 |
| EP4545142A2 (en) | 2025-04-30 |
| FI3801515T3 (fi) | 2025-05-27 |
| US11957670B2 (en) | 2024-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL272444B (en) | Phenyl and heteroaryl derivatives of (1-substituted-piperidin-4- yl)urea, salts thereof and their use for treatment of diseases | |
| DK3820573T3 (da) | 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidin-2,6-dion-derivativer og anvendelse deraf ved behandling af ikaros family zinc finger 2 (ikzf2)-afhængige sygdomme | |
| CY1124088T1 (el) | Παραγωγα 2,4-θειαζολιδινεδιονης στη θεραπεια διαταραχων του κεντρικου νευρικου συστηματος | |
| EP3873897C0 (en) | N-BENZOYL-PHENYLALANINE DERIVATIVES AS INTEGRIN ALPHA4BETA7 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
| HUE070112T2 (hu) | 3-(Kinolin-8-il)-1,4-dihidropirido[3,4-d]pirimidin-2,4-dion-származékok mint alpha4beta7 integrin gátlók gyulladásos betegségek kezelésére | |
| DK3526207T3 (da) | Heterocykliske forbindelser med aktivitet som modulatorer af muscarine m1- og/eller m4-receptorer i behandling af cns-sygdomme og smerter | |
| DK3801515T3 (da) | 5 [[4 [2 [5 (1 hydroxyethyl)pyridin 2 yl]ethoxy]phenyl]methyl] 1,3 thiazolidin 2,4 dion og dets salte til anvendelse i behandlingen af mitokondriesygdomme | |
| CY1126466T1 (el) | Παραγωγα φαινυλιου/πυριδυλ-νη-φαινυλιου/ πυριδυλιου για τη θεραπευτικη αντιμετωπιση ιικωνλοιμωξεων | |
| EP4119140C0 (en) | PHENYLPYRROLE AMINOGUANIDINE DERIVATIVES IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF ARTHRITIC DISEASES | |
| ZA202101490B (en) | 1-methyl-4-[(4-phenylphenyl)sulfonylmethyl]cyclohexyanol and 1-methyl-4-[[4-(2-pyridyl)phenyl]sulfonylmethyl]cyclohexanol compounds and their therapeutic use | |
| IL282375A (en) | 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating α-synucleinopathies, tauopathies, and other disorders | |
| JOP20210313A1 (ar) | مشتقات حلقية غير متجانسة مندمجة | |
| EP3709998B8 (en) | N-[5-(imidazo[1,2-a]pyrimidin-2-yl)phenyl]-benzamide and -benzeneacetamide derivatives as tnf stimulators for the treatment of e.g. infectious diseases and cancer | |
| MX2016005324A (es) | Composiciones pesticidas y metodos relacionados. | |
| DK3559010T3 (da) | Fremgangsmåde til fremstilling af 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedion og salte deraf | |
| DK3515910T3 (da) | 5-[2-(pyridin-2-ylamino)-1,3-thiazol-5-yl]-2,3-dihydro-1h-isoindol-1-onderivater og deres anvendelse som dobbelte inhibitorer af phosphatidylinositol-3-kinase-delta & gamma | |
| MX2023001805A (es) | Formas solidas de 2-(5-(4-(2-morfolinoetoxi)fenil)piridin-2-il)-n- bencilacetamida. | |
| DK4182311T3 (da) | 1-methyl-1h-pyrazol-3-ylderivater til anvendelse til behandling af neovaskulære sygdomme | |
| DK3937948T3 (da) | Phytoecdysoner og derivater deraf til anvendelse i behandlingen af neuromuskulære sygdomme | |
| DK4036095T3 (da) | 4-fluor-1h-pyrazolo[3,4-c]pyridinderivater som selektive bruton-tyrosinkinase- (btk) inhibitorer til behandlingen af b-cellelymfom og autoimmunsygdomme | |
| DK3937949T3 (da) | Phytoecdysoner og derivater deraf til anvendelse i behandlingen af ændret respiratorisk funktion | |
| EP3592772C0 (en) | ANTI-CCL24 (EOTAXIN2) ANTIBODIES FOR USE IN THE TREATMENT OF LIVER DISEASES | |
| IL283956A (en) | Methods and compositions for treating glycogen storage diseases | |
| DK3860598T3 (da) | Vemurafenib og salte heraf til anvendelse til behandling af enterovirusinfektioner | |
| PH12017500124B1 (en) | Azole benzene derivative and crystalline form thereof |